Vaccine Safety & Efficacy
Vaccine efficacy refers to the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.
Related Conference of Vaccine Safety & Efficacy
36th International Conference on Vaccines and Immunization
Vaccine Safety & Efficacy Conference Speakers
Recommended Sessions
- Animal & Plant Derived Vaccines
- Animal Models & Clinical Trials
- Antibodies: Engineering & Therapeutics
- Cancer, Malaria & TB Vaccines
- Cellular Immunology & Latest Innovations
- Combination & Conjugate Vaccines
- Current Research & Future Challenges
- DNA & Synthetic Vaccines
- Fish & Poultry Vaccines
- Geriatric Immunization
- HIV Vaccines
- Paediatric Vaccination
- Travel & Edible Vaccines
- Vaccine Production & Development
- Vaccine Safety & Efficacy
- Vaccines
- Vaccines & Autism
- Vaccines against Drugs
- Vaccines Against Infectious Diseases
- Vaccines for Immune Mediated Diseases
- Vaccines for Pregnant Women & Neonates
- Vaccines for Unconventional Diseases
- Vectors, Adjuvants & Delivery Systems
- Veterinary Vaccines
Related Journals
Are you interested in
- Advances in Vaccine Development - WORLD VACCINES 2025 (France)
- Animal & Plant Derived Vaccines - Vaccine Immunology 2024 (France)
- Animal & Plant Derived Vaccines - Vaccines Summit 2024 (Netherlands)
- Animal Models & Clinical Trials - Vaccine Immunology 2024 (France)
- Animal Models & Clinical Trials - Vaccines Summit 2024 (Netherlands)
- Antibodies: Engineering & Therapeutics - Vaccine Immunology 2024 (France)
- Antibodies: Engineering & Therapeutics - Vaccines Summit 2024 (Netherlands)
- Biomarkers and Immune Monitoring in Vaccines - WORLD VACCINES 2025 (France)
- Cancer BioMarker vaccine - VACCINE CONGRESS 2024 (Spain)
- Cancer Vaccines and Immunotherapy - Euro Vaccines 2024 (Spain)
- Cancer, Malaria & TB Vaccines - Vaccine Immunology 2024 (France)
- Cancer, Malaria & TB Vaccines - Vaccines Summit 2024 (Netherlands)
- Cellular Immunology & Latest Innovations - Vaccine Immunology 2024 (France)
- Cellular Immunology & Latest Innovations - Vaccines Summit 2024 (Netherlands)
- Childhood Vaccines and Maternal Vaccines - Euro Vaccines 2024 (Spain)
- Combination & Conjugate Vaccines - Vaccine Immunology 2024 (France)
- Combination & Conjugate Vaccines - Vaccines Summit 2024 (Netherlands)
- Computational Immunology and Vaccine Modeling - WORLD VACCINES 2025 (France)
- COVID19 Vaccines - VACCINE CONGRESS 2024 (Spain)
- Current Research & Future Challenges - Vaccine Immunology 2024 (France)
- Current Research & Future Challenges - Vaccines Summit 2024 (Netherlands)
- DNA & Synthetic Vaccines - Vaccine Immunology 2024 (France)
- DNA & Synthetic Vaccines - Vaccines Summit 2024 (Netherlands)
- DNA Vaccines - Euro Vaccines 2024 (Spain)
- Emerging Infectious Diseases and Global Health - VACCINES WORLD 2024 (Canada)
- Emerging Infectious Diseases and Vaccine Responses - WORLD VACCINES 2025 (France)
- Ethical and Societal Aspects of Vaccination - VACCINES WORLD 2024 (Canada)
- Fish & Poultry Vaccines - Vaccine Immunology 2024 (France)
- Fish & Poultry Vaccines - Vaccines Summit 2024 (Netherlands)
- Geriatric Immunization - Vaccine Immunology 2024 (France)
- Geriatric Immunization - Vaccines Summit 2024 (Netherlands)
- Geriatric Vaccines - VACCINE CONGRESS 2024 (Spain)
- Global Vaccine Access - VACCINE CONGRESS 2024 (Spain)
- Hepatitis Vaccines - Euro Vaccines 2024 (Spain)
- HIV Vaccines - Vaccine Immunology 2024 (France)
- HIV Vaccines - Vaccines Summit 2024 (Netherlands)
- HIV/AIDS Vaccines - Euro Vaccines 2024 (Spain)
- Human Preventive & Therapeutic Vaccines - Euro Vaccines 2024 (Spain)
- Human Vaccines - Infectious & Non Infectious Diseases - Euro Vaccines 2024 (Spain)
- Immunization in Special Populations - VACCINES WORLD 2024 (Canada)
- Immunodiagnostics and Monitoring Immune Responses - VACCINES WORLD 2024 (Canada)
- Immunogenetics and Personalized Vaccinology - VACCINES WORLD 2024 (Canada)
- Immunogenetics and Vaccine Design - WORLD VACCINES 2025 (France)
- Immunological Memory and Vaccine Boosters - WORLD VACCINES 2025 (France)
- Immunology of Vaccines - VACCINE CONGRESS 2024 (Spain)
- Immunology/Animal Models - Euro Vaccines 2024 (Spain)
- Immunopathology and Host-Pathogen Interactions - VACCINES WORLD 2024 (Canada)
- Immunotherapy and Cancer Vaccines - WORLD VACCINES 2025 (France)
- Innate and Adaptive Immune Responses - VACCINES WORLD 2024 (Canada)
- Innovative Immunotherapies - VACCINES WORLD 2024 (Canada)
- Innovative Vaccine Delivery Systems - WORLD VACCINES 2025 (France)
- Mucosal Immunology and Vaccination - WORLD VACCINES 2025 (France)
- Mucosal Vaccines - Euro Vaccines 2024 (Spain)
- Nanotechnology in Vaccine Development - WORLD VACCINES 2025 (France)
- Next Generation Vaccines - VACCINE CONGRESS 2024 (Spain)
- Next-Generation Sequencing in Immunology Research - WORLD VACCINES 2025 (France)
- Next-Generation Vaccine Delivery Technologies - Euro Vaccines 2024 (Spain)
- Novel Vaccine Platforms - VACCINE CONGRESS 2024 (Spain)
- One Health Approach - VACCINE CONGRESS 2024 (Spain)
- Paediatric Vaccination - Vaccine Immunology 2024 (France)
- Paediatric Vaccination - Vaccines Summit 2024 (Netherlands)
- Paediatric Vaccines - VACCINE CONGRESS 2024 (Spain)
- Pediatric Vaccines and Immunization Strategies - WORLD VACCINES 2025 (France)
- Public Health and Vaccination Programs - VACCINES WORLD 2024 (Canada)
- Therapeutic Vaccines for Chronic Diseases - WORLD VACCINES 2025 (France)
- Travel & Edible Vaccines - Vaccine Immunology 2024 (France)
- Travel & Edible Vaccines - Vaccines Summit 2024 (Netherlands)
- Vaccination Strategies for Vector-Borne Diseases - VACCINES WORLD 2024 (Canada)
- Vaccine Adjuvants - VACCINE CONGRESS 2024 (Spain)
- Vaccine Adjuvants - Euro Vaccines 2024 (Spain)
- Vaccine Adjuvants and Immunomodulators - WORLD VACCINES 2025 (France)
- Vaccine Clinical Trials - VACCINE CONGRESS 2024 (Spain)
- Vaccine Delivery Systems - VACCINE CONGRESS 2024 (Spain)
- Vaccine Development and Design - VACCINES WORLD 2024 (Canada)
- Vaccine Development for Emerging Diseases - VACCINE CONGRESS 2024 (Spain)
- Vaccine Development for Zoonotic Diseases - WORLD VACCINES 2025 (France)
- Vaccine Economics and Market Access - VACCINES WORLD 2024 (Canada)
- Vaccine Education and Advocacy - VACCINES WORLD 2024 (Canada)
- Vaccine Equity - VACCINE CONGRESS 2024 (Spain)
- Vaccine Financing - VACCINE CONGRESS 2024 (Spain)
- Vaccine Hesitancy - VACCINE CONGRESS 2024 (Spain)
- Vaccine Hesitancy and Public Health Communication - WORLD VACCINES 2025 (France)
- Vaccine Immunogenicity - VACCINE CONGRESS 2024 (Spain)
- Vaccine Manufacturing - VACCINE CONGRESS 2024 (Spain)
- Vaccine Policy and Regulation - VACCINE CONGRESS 2024 (Spain)
- Vaccine Policy and Regulatory Affairs - WORLD VACCINES 2025 (France)
- Vaccine Production & Development - Vaccine Immunology 2024 (France)
- Vaccine Production & Development - Vaccines Summit 2024 (Netherlands)
- Vaccine Research & Development - Euro Vaccines 2024 (Spain)
- Vaccine Safety - VACCINE CONGRESS 2024 (Spain)
- Vaccine Safety & Efficacy - Vaccines Summit 2024 (Netherlands)
- Vaccine Safety and Adverse Event Monitoring - VACCINES WORLD 2024 (Canada)
- Vaccine Safety and Efficacy - WORLD VACCINES 2025 (France)
- Vaccine Strategies for Autoimmune Diseases - WORLD VACCINES 2025 (France)
- Vaccine Surveillance - VACCINE CONGRESS 2024 (Spain)
- Vaccines - Vaccine Immunology 2024 (France)
- Vaccines - Vaccines Summit 2024 (Netherlands)
- Vaccines & Autism - Vaccine Immunology 2024 (France)
- Vaccines & Autism - Vaccines Summit 2024 (Netherlands)
- Vaccines against Drugs - Vaccines Summit 2024 (Netherlands)
- Vaccines against Drugs - Vaccine Immunology 2024 (France)
- Vaccines against Infectious Diseases - Vaccine Immunology 2024 (France)
- Vaccines Against Infectious Diseases - Vaccines Summit 2024 (Netherlands)
- Vaccines against Viral and Bacterial Diseases - Euro Vaccines 2024 (Spain)
- Vaccines Business Development - Euro Vaccines 2024 (Spain)
- Vaccines Epidemiology - VACCINE CONGRESS 2024 (Spain)
- Vaccines for Immune Mediated Diseases - Vaccine Immunology 2024 (France)
- Vaccines for Immune Mediated Diseases - Vaccines Summit 2024 (Netherlands)
- Vaccines for Neglected Tropical Diseases - WORLD VACCINES 2025 (France)
- Vaccines for Non-Communicable Diseases - VACCINES WORLD 2024 (Canada)
- Vaccines for Older Adults - Euro Vaccines 2024 (Spain)
- Vaccines for Pregnant Women & Neonates - Vaccine Immunology 2024 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines Summit 2024 (Netherlands)
- Vaccines for Respiratory Diseases - Euro Vaccines 2024 (Spain)
- Vaccines for Unconventional Diseases - Vaccine Immunology 2024 (France)
- Vaccines for Unconventional Diseases - Vaccines Summit 2024 (Netherlands)
- Vaccines for Vector-borne Diseases - Euro Vaccines 2024 (Spain)
- Vaccines Immunology - VACCINE CONGRESS 2024 (Spain)
- Vaccines Safety & Efficacy - Euro Vaccines 2024 (Spain)
- Vectors, Adjuvants & Delivery Systems - Vaccine Immunology 2024 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines Summit 2024 (Netherlands)
- Veterinary Vaccines - Vaccines Summit 2024 (Netherlands)
- Veterinary Vaccines - Euro Vaccines 2024 (Spain)